Bibliografías temáticas / Pulmonary Pathophysiology

Índice

  1. Artículos de revistas
  2. Tesis
  3. Libros
  4. Capítulos de libros
  5. Actas de conferencias
  6. Informes

Literatura académica sobre el tema "Pulmonary Pathophysiology"

Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 19 de febrero de 2022

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Pulmonary Pathophysiology".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Pulmonary Pathophysiology"

1

Cherniack, Neil S. "Pulmonary Pathophysiology". Annals of Internal Medicine 131, n.º 5 (7 de septiembre de 1999): 399. http://dx.doi.org/10.7326/0003-4819-131-5-199909070-00022.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Gonzalez, Norberto C. "PULMONARY PATHOPHYSIOLOGY". Shock 11, n.º 2 (febrero de 1999): 152. http://dx.doi.org/10.1097/00024382-199902000-00018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Grippi, Michael A. "PULMONARY PATHOPHYSIOLOGY". Shock 5, n.º 4 (abril de 1996): 311. http://dx.doi.org/10.1097/00024382-199604000-00013.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Chamarthy, Murthy R., Asha Kandathil y Sanjeeva P. Kalva. "Pulmonary vascular pathophysiology". Cardiovascular Diagnosis and Therapy 8, n.º 3 (junio de 2018): 208–13. http://dx.doi.org/10.21037/cdt.2018.01.08.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Gao, Yuansheng y J. Usha Raj. "Pathophysiology of Pulmonary Hypertension". Colloquium Series on Integrated Systems Physiology: From Molecule to Function 9, n.º 6 (22 de noviembre de 2017): i—104. http://dx.doi.org/10.4199/c00158ed1v01y201710isp078.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Angerio, Allan D. y Peter A. Kot. "Pathophysiology of pulmonary edema". Critical Care Nursing Quarterly 17, n.º 3 (noviembre de 1994): 21–26. http://dx.doi.org/10.1097/00002727-199411000-00004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Higenbottam, Tim. "Pathophysiology of Pulmonary Hypertension". Chest 105, n.º 2 (febrero de 1994): 7S—12S. http://dx.doi.org/10.1378/chest.105.2_supplement.7s.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Klayton, Ronald J. "PULMONARY PATHOPHYSIOLOGY — THE ESSENTIALS". Military Medicine 158, n.º 2 (1 de febrero de 1993): A9. http://dx.doi.org/10.1093/milmed/158.2.a9a.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Shibuya, Kazutoshi, Chikako Hasegawa, Shigeharu Hamatani, Tsutomu Hatori, Tadashi Nagayama, Hiroko Nonaka, Tsunehiro Ando y Megumi Wakayama. "Pathophysiology of pulmonary aspergillosis". Journal of Infection and Chemotherapy 10, n.º 3 (2004): 138–45. http://dx.doi.org/10.1007/s10156-004-0315-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Matthay, Michael A. "Pathophysiology of Pulmonary Edema". Clinics in Chest Medicine 6, n.º 3 (septiembre de 1985): 301–14. http://dx.doi.org/10.1016/s0272-5231(21)00366-x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Pulmonary Pathophysiology"

1

Walsh, Robert Leo. "Leukocyte elastase and anti-elastases in pulmonary emphysema". Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phw2261.pdf.

Texto completo
Resumen
Includes bibliographical references (leaves 218-249) The preferred theory to explain the aetiology of emphysema points to an imbalance in the protease-antiprotease systems within the lung with human leukocyte elastase and [alpha]1-protease inhibiter being the main candidates. Examines some aspects of this theory.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Muzaffar, Saima. "Reactive oxygen species and the pathophysiology of adult respiratory distress syndrome". Thesis, University of Bristol, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271916.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Tauriainen, M. Peter. "Negative pressure pulmonary edema, a clinical review and study of its pathophysiology". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq23521.pdf.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Otsuka, Kojiro. "Sputum YKL-40 Levels and Pathophysiology of Asthma and Chronic Obstructive Pulmonary Disease". Kyoto University, 2012. http://hdl.handle.net/2433/152498.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

McLennan, Geoffrey. "Oxygen toxicity and radiation injury to the pulmonary system". Title page, index and forward only, 1997. http://web4.library.adelaide.edu.au/theses/09PH/09phm164.pdf.

Texto completo
Resumen
Bibliography: leaves 168-184. The work in this study encompasses oxygen free radical related inflammation in the peripheral lung and in lung cells. Animal and human studies have been used. Methods include cell culture with function studies, protein chemistry, animal and human physiology, and cell and lung structure through histopathology, and various forms of electron microscopy. The work resulting from this thesis has formed an important basis for understanding acute and chronic lung injury.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Mittal, Manish [Verfasser]. "Role of NADPH oxidases and KDR channels in the pathophysiology of hypoxia induced pulmonary hypertension / Manish Mittal". Gießen : Universitätsbibliothek, 2009. http://d-nb.info/1060563207/34.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Mason, Nicholas. "Mechanisms of altitude-related cough". Doctoral thesis, Universite Libre de Bruxelles, 2012. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209711.

Texto completo
Resumen
The original work presented in this thesis investigates some of the mechanisms that may be responsible for the aetiology of altitude-related cough. Particular attention is paid to its relationship to the long recognised, but poorly understood, changes in lung volumes that occur on ascent to altitude. The literature relevant to this thesis is reviewed in Chapter 1.

Widespread reports have long existed of a debilitating cough affecting visitors to high altitude that can incapacitate the sufferer and, on occasions, be severe enough to cause rib fractures (22, 34, 35). The prevalence of cough at altitude has been estimated to be between 22 and 42% at between 4200 and 4900 m in the Everest region of Nepal (10, 29). Traditionally the cough was attributed to the inspiration of the cold, dry air characteristic of the high altitude environment (37) but no attempts were made to confirm this aetiology. In the first formal study of cough at high altitude, nocturnal cough frequency was found to increase with increasing altitude during a trek to Everest Base Camp (5300 m) and massively so in 3 climbers on whom recordings were made up to 7000 m on Everest (8). After 9 days at 5300 m the citric acid cough threshold, a measure of the sensitivity of the cough reflex arc, was significantly reduced compared with both sea level and arrival at 5300 m.

During Operation Everest II, a simulated climb of Mount Everest in a hypobaric chamber, the majority of the subjects were troubled above 7000 m by pain and dryness in the throat and an irritating cough despite the chamber being maintained at a relative humidity of between 72 and 82% and a temperature of 23ºC (18). This argued against the widely held view that altitude-related cough was due to the inspiration of cold, dry air.

In the next major hypobaric chamber study, Operation Everest III, nocturnal cough frequency and citric acid cough threshold were measured on the 8 subjects in the study. The chamber temperature was maintained between 18 and 24ºC and relative humidity between 30 and 60% (24). This work is presented in Chapter 2 and, demonstrated an increase in nocturnal cough frequency with increasing altitude which immediately returned to control values on descent to sea level. Citric acid cough threshold was reduced at 8000 m compared to both sea level and 5000 m values. Changes in citric acid cough threshold at lower altitudes may not have been detected because of the constraints on subject numbers in the chamber. The study still however demonstrated an increase in clinical cough and a reduction in the citric acid cough threshold at extreme altitude, despite controlled environmental conditions, and thus refuted the long held belief that altitude-related cough is solely due to the inspiration of cold, dry air.

If altitude-related cough is not simply due to the inspiration of cold, dry air, other possible aetiologies are:

•\
Doctorat en Sciences médicales
info:eu-repo/semantics/nonPublished

Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Yoshioka, Eliane Muta. "Alterações pulmonares e sistêmicas em modelo de lesão pulmonar aguda de etiologia pulmonar e extra pulmonar após ventilação mecânica de curto prazo". Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5144/tde-03092010-144329/.

Texto completo
Resumen
A inflamação pulmonar pode variar de acordo com o sitio primário da injuria e poder ser afetado pelo estresse mecânico gerado pela ventilação mecânica. (VM) Objetivos: estudar as eventuais diferenças na reposta pulmonar e sistêmica na lesão pulmonar aguda pulmonar (LPA P ) e extra pulmonar (LPA Exp) após ventilação mecânica. Métodos: Camundongos BALB/c foram divididos em doze grupos. Os grupos controle pulmonar (CP) e extra pulmonar (C Exp) receberam solução salina (SAL) ou Lipopolissacarideo (LPS) via intratraqueal (IT) ou intraperitoneal (IP) respectivamente. Os grupos foram submetidos ou não a simples manobra de pressurização (SMP) até 45 cm H2O. Resultados: Os grupos LPAP e LPAExp não ventilados apresentaram o mesmo nível de inflamação; uma diferença estatisticamente significativa na densidade de células inflamatórias foi observada no grupo LPA P VM (3,84±1,28 cels/2) comparado ao grupo LPA Exp VM ((1,75±0,14 cels/2), p=0,013. O mesmo foi observado na LPA P SMP (2,92±0,44 cels/2) comparado ao LPA Exp SMP (1,46±0,23 cels/2), p<0,0001. LPAP mostrou estatisticamente significante aumento no El (56,19 ± 12,26 cm H2O) em comparação ao LPA Exp SMP (26,88 ± 36,38 cm H2O) após SMP (p = 0,029). Nenhuma diferença estatisticamente significante foi observada no estresse oxidativo no rim. Conclusão: Observamos um padrão diferente da resposta inflamatória e mecânica pulmonar comparando LPA pulmonar e extra-pulmonar submetido à ventilação mecânica de curto prazo. Embora a ventilação mecânica represente uma ferramenta essencial para estabilizar o paciente critico, é necessário individualizar a abordagem do tratamento ventilatório
Lung inflammation may vary according to the primary site of injury and may be affected by the mechanical stress generated by mechanical ventilation (MV). Objectives: to address possible differences in lung and systemic responses in pulmonary and extra pulmonary ALI after mechanical ventilation. Methods: BALB/c mice were divided in twelve groups of six animals. In pulmonary and extrapulmonary control or ALI groups received either saline or LPS (intratracheally instilled or intraperitoneally injected), respectively. Ventilated groups were either recruited or not with a single recruitment maneuver (SRM) reaching 45 cm H2O. Results: At baseline ALI P and ALI EXP non ventilated groups presented the same level of inflammation; a statistically significant difference in density of inflammatory cells was noted in ALI P MV (3,84±1,28 cells/2) compared to ALI EXP MV (1,75±0,14 cells/2), p=0,013. The same was observed in ALI P SRM (2,92±0,44 cells/2) compared to ALI EXP SRM (1,46±0,23 cells/2) ventilated groups (p<0,0001). ALI P showed a statistically significant increase in El (56,19 ± 12,26 cm H2O) in comparison to ALI EXP (26,88 ± 36,38 cm H2O) after SRM (p = 0,029). No statistical differences were observed in kidney oxidative stress. Conclusion: We observed a different pattern of response in lung inflammation and mechanics comparing pulmonary and extra pulmonary ALI, submitted to short term mechanical ventilation. Although mechanical ventilation represents a fundamental tool to stabilize critical patients, it is essential to individualize the approach of the ventilatory treatment
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Rondelet, Benoît. "Médiation humorale de l'hypertension artérielle pulmonaire dans un modèle de cardiopathie congénitale à shunt systémo-pulmonaire chez le porcelet en croissance". Doctoral thesis, Universite Libre de Bruxelles, 2008. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210373.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Aissa, Jamal. "Pathophysiologie et pharmacologie cardio-pulmonaire et inflammatoire du PAF-ACETHER". Paris 5, 1993. http://www.theses.fr/1993PA05CD07.

Texto completo
Resumen
Le paf-acéther (paf) est un médiateur pro inflammatoire dérivé du métabolisme des lipides constitutifs des membranes cellulaires. Nous avons étudié les effets physiothologiques du paf dans le domaine cardio-pulmonaire et lors d'une inflammation locale et articulaire. L'injection de ce médiateur dans la circulation pulmonaire chez la brebis induit une thrombocytopénie et une leucopénie immédiate puis une accumulation leucocytaire pulmonaire décelable à la 5ème minute. On observe une hypertension pulmonaire indépendante du thromboxane B2 (TxB2). Toutes les réponses induites par le paf sont inhibées par un antagoniste spécifique de ce médiateur, le WEB 2086. L'administration du complexe héparine-protamine chez le lapin s'accompagne d'une production transitoire de paf associée à une thrombocytopénie et à une leucopénie et d'une production retardée mais prolongée de TxB2. L'effet protecteur du BN 52021, autre antagoniste spécifique du paf, sur la trombocytopénie et le niveau plasmique du TxB2 indique d'une part que le paf exerce un rôle précoce au niveau cellulaire, d'autre part que la production de TxB2 est partiellement médiée par le paf. Notre travail a également montré l'implication du paf dans l'arthrite induite par la carragénie chez le lapin, notamment dans sa phase aiguë. Un antagoniste spécifique du paf, le BN 50730, exerce une action préventive et curative sur l'arthrite. Dans le modèle du granulome inflammatoire induit par la carragénine chez le rat, le paf est produit in situ au cours de la phase aiguë mais également au cours du passage à la phase chronique ce qui suggère son implication à cette étape de la réaction inflammatoire. L'action du paf doit se concevoir en fonction de ses nombreux effets cellulaires et de ses interrelations avec d'autres médiateurs de l'inflammation. Les effets bénéfiques des antagonistes des récepteurs au paf pourraient représenter une alternative thérapeutique et un intérêt clinique, notamment dans l'inflammation chronique.
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Pulmonary Pathophysiology"

1

Pulmonary pathophysiology. Philadelphia: Lippincott, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Pulmonary pathophysiology: The essentials. 7a ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

B, West John, ed. Pulmonary pathophysiology--the essentials. 4a ed. Baltimore: Williams & Wilkins, 1992.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

West, John B. (John Burnard), ed. Pulmonary pathophysiology: The essentials. 8a ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2012.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Pulmonary pathophysiology: The essentials. 3a ed. Baltimore: Williams & Wilkins, 1987.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

B, West John, ed. Pulmonary pathophysiology--the essentials. 5a ed. Baltimore, Md: Williams & Wilkins, 1998.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Pulmonary pathophysiology: A clinical approach. 3a ed. New York: McGraw-Hill Medical, 2010.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Workshop on "Chronic Pulmonary Hyperinflation" (1988 Montescano, Italy). Chronic pulmonary hyperinflation. London: Springer-Verlag, 1989.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Pulmonary circulation: Diseases and their treatment. 3a ed. London: Hodder Arnold, 2011.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Bittar, E. Edward. Pulmonary biology in health and disease. Editado por Springer-Verlag. New York: Springer, 2002.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Pulmonary Pathophysiology"

1

Kaul, Sunny. "Pathophysiology". En Managing Chronic Obstructive Pulmonary Disease, 1–12. West Sussex, England: John Wiley & Sons Ltd, 2008. http://dx.doi.org/10.1002/9780470697603.ch1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Vanzeller, Mafalda, Marta Drummond y João Carlos Winck. "Chronic respiratory failure – pathophysiology". En Pulmonary Rehabilitation, 399–408. Second edition. | Boca Raton : CRC Press, [2020] | Preceded by Pulmonary rehabilitation / Claudio F. Donner, Nicolino Ambrosino, Roger Goldstein. 2005.: CRC Press, 2020. http://dx.doi.org/10.1201/9781351015592-41.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Rabinovitch, Marlene. "Pulmonary Vascular Pathophysiology". En Pediatric Cardiovascular Medicine, 71–80. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444398786.ch5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Lajoie, Annie C., Vincent Mainguy, SéBastien Bonnet y Steeve Provencher. "Pulmonary vascular diseases". En Applied Respiratory Pathophysiology, 119–47. Boca Raton : CRC Press, [2017]: CRC Press, 2017. http://dx.doi.org/10.1201/9781315177052-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Milot, Julie y Mathieu Morissette. "Chronic obstructive pulmonary disease". En Applied Respiratory Pathophysiology, 97–118. Boca Raton : CRC Press, [2017]: CRC Press, 2017. http://dx.doi.org/10.1201/9781315177052-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Schols, Annemie M. W. J. y Emiel F. M. Wouters. "Pulmonary rehabilitation". En Recent Advances in the Pathophysiology of COPD, 167–87. Basel: Birkhäuser Basel, 2004. http://dx.doi.org/10.1007/978-3-0348-7939-2_11.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Schrump, David S. "Pulmonary Malignancies: Pathophysiology and Treatment". En Principles and Practice of Geriatric Surgery, 406–32. New York, NY: Springer New York, 2001. http://dx.doi.org/10.1007/978-1-4757-3432-4_29.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Rizzo, Alicia N., Dustin R. Fraidenburg y Jason X. J. Yuan. "Pulmonary Vascular Physiology and Pathophysiology". En PanVascular Medicine, 4057–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-37078-6_202.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Rizzo, Alicia N., Dustin R. Fraidenburg y Jason X. J. Yuan. "Pulmonary Vascular Physiology and Pathophysiology". En PanVascular Medicine, 1–26. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-37393-0_202-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Mitani, Yoshihide. "Pathophysiology and Genetics: BMPR2". En Diagnosis and Treatment of Pulmonary Hypertension, 115–24. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-287-840-3_9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Pulmonary Pathophysiology"

1

Zhao, Y. C., S. E. Rees, S. Andreassen y S. Kjaergaard. "Simulation of Pulmonary Pathophysiology During Spontaneous Breathing". En 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference. IEEE, 2005. http://dx.doi.org/10.1109/iembs.2005.1615892.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Ghanem, M., A. Justet, M. Jaillet, M. Hachem, T. Boghanim, A. Vadel, A. Mailleux y B. Crestani. "Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology". En American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4220.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Lammers, Steven R., Phil H. Kao, Lian Tian, Kendall Hunter, H. Jerry Qi, Joseph Albietz, Stephen Hofmeister, Kurt Stenmark y Robin Shandas. "Quantification of Elastin Residual Stretch in Fresh Artery Tissue: Impact on Artery Material Properties and Pulmonary Hypertension Pathophysiology". En ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206793.

Texto completo
Resumen
Pulmonary arterial hypertension (PAH) is characterized as a chronic elevation in mean pulmonary artery pressure (MPAP) resulting from increased hydrodynamic resistance and decreased hydraulic capacitance of the pulmonary circulatory system. These hemodynamic changes cause the heart to operate outside optimum pump efficiency. The heart compensates for the efficiency loss through ventricular hypertrophy which, if left untreated, will continue until cardiac failure results.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Siler, S. Q., D. Longo, J. Woodhead, C. Battista, Z. Kenz, S. Tallapaka, G. Liu, G. Generaux, S. Ermakov y L. Shoda. "Using Quantitative Systems Pharmacology Modeling to Understand the Pathophysiology of Idiopathic Pulmonary Fibrosis". En American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4648.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Alamer, Amal, Rhys Jones, Chris Ward, Michael Drinnan, Alexander John Simpson, Michael Griffin, Joanne Patterson y Ian Forrest. "Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series". En ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3370.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Dumas, Sébastien J., Frédéric Perros, Catherine Rucker-Martin, Elodie Gouadon, Marc J. C. Humbert y Sylvia Cohen-Kaminsky. "Glutamate And NMDA Receptors: New Signaling Pathway Involved In The Pathophysiology Of Pulmonary Hypertension". En American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4747.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Alamer, A., R. Jones, C. Ward, M. Drinnan, AJ Simpson, M. Griffin, J. Patterson y I. Forrest. "S127 Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series". En British Thoracic Society Winter Meeting, Wednesday 17 to Friday 19 February 2021, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2021. http://dx.doi.org/10.1136/thorax-2020-btsabstracts.132.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

He, M., K. Qing, N. Tustison, L. A. Myc, J. MacLeod, R. Nunoo-Asare, J. Cassani et al. "Probing Early-Stage Pulmonary Pathophysiology in Young Healthy E-cigarettes Users Using Hyperpolarized 129Xe MRI". En American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1113.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Tan, Yan y Wei Tan. "Reducing Upstream Compliance Induces Downstream High Pulsatility Flow-Dependent Inflammatory Response in Pulmonary Endothelial Cells via TLR2/NF-KB Pathway". En ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80900.

Texto completo
Resumen
Pulmonary arterial hypertension (PAH) is a group of chronic, progressive and fatal diseases, characterized by the dysfunction of the small arteries and microvasculature in the pulmonary circulation. Due to high blood pressure and high resistance in the pulmonary arteries, PAH causes detrimental damage on the lung and right heart ventricle. If left untreated, PAH quickly becomes life threatening. Although the exact pathophysiology remains unknown, there is increasing evidence suggesting that inflammation likely plays an important role in inducing and perpetuating the PAH progress. Although anti-inflammatory therapy has been shown effective in certain connective-tissue-disease-associated PAH, this approach has not been tested in other PAH conditions. The potential benefit of anti-inflammatory therapy to treat various PAH conditions could be of importance and require further study on the possible pathological mechanisms underlying the therapeutic effects.
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Lee, Namheon, Michael D. Taylor, Kan N. Hor y Rupak K. Banerjee. "Non-Invasive Calculation of Energy Loss in Pulmonary Arteries Using 4D Phase Contrast MRI Measurement". En ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80525.

Texto completo
Resumen
The recent development of energy based endpoints, to quantify the pathophysiology of congenital heart disease such as tetralogy of Fallot (TOF), requires accurate measurement of cardiac blood flow and pressure data. Consequently, invasive cardiac catheterization is required for those measurements. In this research we used 4D phase contrast magnetic resonance imaging (PC MRI) data to determine the pressure drop non-invasively. This enables us to obtain pressure-flow variation, which, in turn, allowed us to calculate energy loss along the branch pulmonary arteries (PA). Based on our result, we believe that the hemodynamic status of the PA of a subject can be non-invasively evaluated by both pressure drop and energy loss values along the PA.
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Pulmonary Pathophysiology"

1

Hurt, Holcombe H., Suzanne A. Hernandez, Wallace B. Baze, Theresa M. Tezak-Reid y Jill R. Keeler. Pathophysiologic Mechanisms of Three Pulmonary Edemagenic Compounds: The Role of Toxic Oxygen Species. Fort Belvoir, VA: Defense Technical Information Center, abril de 1992. http://dx.doi.org/10.21236/ada251135.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Pulmonary Pathophysiology" para tipos de fuentes particulares:
Artículos de revistas Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía